...
首页> 外文期刊>Endocrine. >Day-night variations in thyroid stimulating hormone and its relation with clinical status and metabolic parameters in patients with cirrhosis of the liver
【24h】

Day-night variations in thyroid stimulating hormone and its relation with clinical status and metabolic parameters in patients with cirrhosis of the liver

机译:甲状腺刺激激素的昼夜变异及其与肝硬化肝硬化患者临床状态和代谢参数的关系

获取原文
获取原文并翻译 | 示例

摘要

To investigate day-night variations in thyroid stimulating hormone (TSH) and its relation with clinical status and metabolic parameters in patients with cirrhosis. Forty-one patients with negative thyroid antibodies and normal thyroid function tests who were diagnosed with cirrhosis were included. Thirty-five age-and gender-matched healthy subjects were included in control group. TSH, fT3, and fT4 levels, which were measured both in the morning and late evening. The difference between nocturnal TSH and morning TSH (Delta TSH) were compared between groups. Relation between Child-Turcotte-Pugh, model for End-Stage Liver Disease (MELD) and MELD-Na scores and levels of thyroid hormones, Delta TSH and serum sodium (Na) levels was investigated. Relation between Delta TSH and clinical status and metabolic parameters was also evaluated. The mean morning fT3, nocturnal fT3, nocturnal TSH, and Delta TSH levels were significantly lower, morning and nocturnal fT4 levels were higher in patients with cirrhosis (p < 0.001, p < 0.001, p = 0.004, p < 0.001, and p < 0.001). As the ROC analysis, day-night variation was detected to be impaired in the event that difference between nocturnal TSH level and morning TSH level was lower than 1 uIU/mL in patients with cirrhosis with a sensitivity of 92.7 % and specificity of 71.4 % (p < 0.001). A significant positive correlation was found between serum Na levels and fT3 in patients with cirrhosis (r = 0.479, p = 0.001), and a significant negative correlation was found between the severity of clinical status and low levels of fT3 in patients with cirrhosis (p < 0.001). Nocturnal TSH increase does not occur in cases of cirrhosis without known thyroid disease and with normal thyroid function tests, which may be an early finding of impaired thyroid functions in patients with cirrhosis.
机译:研究甲状腺刺激激素(TSH)的昼夜变异及其与肝硬化患者临床状态和代谢参数的关系。包括患有肝硬化患者的40-一名负甲状腺抗体和正常的甲状腺功能试验。对照组中包含三十五岁和性别匹配的健康受试者。 TSH,FT3和FT4水平,在早上和深夜均测量。在组之间比较了夜间TSH和MORTONT TSH(DELTA TSH)之间的差异。研究了儿童扁桃-PUGH之间的关系,终末期肝病(MELD)和MELD-NA评分以及甲状腺激素,DELTA TSH和血清钠(NA)水平的水平。还评估了Delta TSH和临床状态和代谢参数之间的关系。平均早上FT3,夜行症FT3,夜间TSH和Delta TSH水平显着降低,肝硬化患者的早晨和夜间FT4水平较高(P <0.001,P <0.001,P = 0.004,P <0.001和P < 0.001)。作为ROC分析,在夜间TSH水平和早晨TSH水平的差异低于肝硬化患者的情况下,检测到日夜变异在肝硬化患者中低于1 UIU / mL,敏感性为92.7%,特异性为71.4%( p <0.001)。在肝硬化患者(R = 0.479,P = 0.001)之间的血清NA水平和FT3之间发现了显着的阳性相关性,并且在肝硬化患者的临床状态和低水平的FT3的严重程度之间发现了显着的负相关(P <0.001)。在没有已知的甲状腺疾病的情况下,在肝硬化和正常的甲状腺功能试验中不会发生夜间TSH增加,这可能是肝硬化患者患者患者的早期发现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号